EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
1.500
-0.025 (-1.64%)
Jul 14, 2025, 4:00 PM - Market closed
EDAP TMS Revenue
EDAP TMS had revenue of 13.56M EUR in the quarter ending March 31, 2025, a decrease of -9.05%. This brings the company's revenue in the last twelve months to 62.77M, up 3.69% year-over-year. In the year 2024, EDAP TMS had annual revenue of 64.12M with 6.11% growth.
Revenue (ttm)
62.77M EUR
Revenue Growth
+3.69%
P/S Ratio
0.84
Revenue / Employee
202,471 EUR
Employees
310
Market Cap
56.09M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EDAP News
- 13 days ago - EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status - GlobeNewsWire
- 6 weeks ago - EDAP to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - EDAP TMS S.A. (EDAP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - EDAP Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025 - GlobeNewsWire
- 2 months ago - EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 2 months ago - EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 2 months ago - EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting - GlobeNewsWire